Pearce Catherine

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 49% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pearce Catherine's trades of CinCor Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
227.21
Quantity 58,389 -14.1%
Value US$154,013
Transaction date
Purchase
Price
151.01
Quantity 10,475 +32.1%
Value US$2,612,219
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-01-13 2022-01-11
B Purchase
58,389 -14.1%
227.21
US$154,013 		58,389 -14.1% 227.21 US$154,013
2022-01-13 2022-01-11
B Purchase
10,475 +32.1%
151.01
US$2,612,219 		10,475 +32.1% 151.01 US$2,612,219